Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Telapristone

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Telapristone
Clinical data
Other namesCDB-4124; Proellex; Progenta; 17β-(Acetyloxy)-11β-[4-(dimethylamino)phenyl]-17α-(2-methoxyacetyl)estra-4,9-dien-3-one
Drug classSelective progesterone receptor modulator
Legal status
Legal status
  • Investigational
Identifiers
  • [(8S,11R,13S,14S,17R)-11-[4-(Dimethylamino)phenyl]-17-(2-methoxyacetyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
CAS Number
PubChemCID
PubChem SID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC31H39NO5
Molar mass505.655 g·mol−1
3D model (JSmol)
  • O=C5\C=C3/C(=C2/[C@@H](c1ccc(N(C)C)cc1)C[C@@]4([C@@](OC(=O)C)(C(=O)COC)CC[C@H]4[C@@H]2CC3)C)CC5
  • InChI=1S/C31H39NO5/c1-19(33)37-31(28(35)18-36-5)15-14-27-25-12-8-21-16-23(34)11-13-24(21)29(25)26(17-30(27,31)2)20-6-9-22(10-7-20)32(3)4/h6-7,9-10,16,25-27H,8,11-15,17-18H2,1-5H3/t25-,26+,27-,30-,31-/m0/s1 checkY
  • Key:JVBGZFRPTRKSBB-MJBQOYBXSA-N checkY
  (verify)

Telapristone (INNTooltip International Nonproprietary Name), astelapristone acetate (proposed brand namesProellex,Progenta; former code nameCDB-4124), is asynthetic,steroidalselective progesterone receptor modulator (SPRM) related tomifepristone which is under development by Repros Therapeutics for the treatment ofbreast cancer,endometriosis, anduterine fibroids.[1][2] It was originally developed by theNational Institutes of Health (NIH), and, as of 2017, is inphase IIclinical trials for the aforementioned indications.[1] In addition to its activity as an SPRM, the drug also has someantiglucocorticoid activity.[3]

See also

[edit]

References

[edit]
  1. ^ab"Telapristone - Repros Therapeutics - AdisInsight".
  2. ^Attardi BJ, Burgenson J, Hild SA, Reel JR (2004). "In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone".J. Steroid Biochem. Mol. Biol.88 (3):277–88.doi:10.1016/j.jsbmb.2003.12.004.PMID 15120421.S2CID 23958876.
  3. ^Whitaker LH, Williams AR, Critchley HO (2014). "Selective progesterone receptor modulators".Curr. Opin. Obstet. Gynecol.26 (4):237–42.doi:10.1097/GCO.0000000000000082.PMID 24950125.S2CID 37474964.

External links

[edit]


Progestogens
(andprogestins)
PRTooltip Progesterone receptoragonists
Antiprogestogens
SPRMsTooltip Selective progesterone receptor modulators
PRTooltip Progesterone receptorantagonists
PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
GRTooltip Glucocorticoid receptor
Agonists
Mixed
(SEGRMsTooltip Selective glucocorticoid receptor agonists)
Antagonists
Others


This article about anestrane is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Telapristone&oldid=1320706350"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp